You are currently viewing a new version of our website. To view the old version click .

Cancers, Volume 11, Issue 4

April 2019 - 155 articles

Cover Story: With this work, we provide mechanistic evidence that ANXA2, via its reactive Cys-8 residue, binds to PTEN and that co-expression of PTEN and ANXA2 inhibits AKT phosphorylation on Ser473. These data together with our observation that ANXA2 depleted cells show enhanced phosphorylation of AKT following either EGF/EGFR activation or RasV12 transformation compared to controls support that direct regulation of PTEN by ANXA2 might constitute an important mechanism in regulating AKT following H2O2-dependent signaling. Furthermore, we reveal that ANXA2 inversely regulates the expression of the peroxidase, PRDX2, in a ROS-dependent manner. The activation of the EGF/PI3K/AKT or RAS/PI3K/AKT networks enables Rac to bind to and activate NOX. This drives the increase in intracellular H2O2 and induces PRDX2 to compensate for the REDOX unbalance in ANXA2 depleted cells. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (155)

  • Article
  • Open Access
16 Citations
4,586 Views
13 Pages

Acute Hypoxia Profile is a Stronger Prognostic Factor than Chronic Hypoxia in Advanced Stage Head and Neck Cancer Patients

  • Martijn van der Heijden,
  • Monique C. de Jong,
  • Caroline V. M. Verhagen,
  • Reinout H. de Roest,
  • Sebastian Sanduleanu,
  • Frank Hoebers,
  • C. René Leemans,
  • Ruud H. Brakenhoff,
  • Conchita Vens and
  • Marcel Verheij
  • + 1 author

25 April 2019

Hypoxic head and neck tumors respond poorly to radiotherapy and can be identified using gene expression profiles. However, it is unknown whether treatment outcome is driven by acute or chronic hypoxia. Gene expression data of 398 head and neck cancer...

  • Article
  • Open Access
14 Citations
4,957 Views
14 Pages

Differential Activation of ERK Signaling in HPV-Related Oropharyngeal Squamous Cell Carcinoma

  • Chao Rong,
  • Marie Muller,
  • Christa Flechtenmacher,
  • Dana Holzinger,
  • Gerhard Dyckhoff,
  • Olcay Cem Bulut,
  • Dominik Horn,
  • Peter Plinkert,
  • Jochen Hess and
  • Annette Affolter

25 April 2019

Human papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma (OPSCC) forms a distinct tumor entity with better survival clinical outcome. Numerous underlying molecular mechanisms have been postulated for differences in treatment response,...

  • Article
  • Open Access
12 Citations
5,754 Views
19 Pages

Deletions of Chromosome 7q Affect Nuclear Organization and HLXB9Gene Expression in Hematological Disorders

  • Concetta Federico,
  • Temitayo Owoka,
  • Denise Ragusa,
  • Valentina Sturiale,
  • Domenica Caponnetto,
  • Claudia Giovanna Leotta,
  • Francesca Bruno,
  • Helen A. Foster,
  • Silvia Rigamonti and
  • Giovanni Giudici
  • + 5 authors

25 April 2019

The radial spatial positioning of individual gene loci within interphase nuclei has been associated with up- and downregulation of their expression. In cancer, the genome organization may become disturbed due to chromosomal abnormalities, such as tra...

  • Article
  • Open Access
47 Citations
6,993 Views
15 Pages

Chromogranin A in the Laboratory Diagnosis of Pheochromocytoma and Paraganglioma

  • Radovan Bílek,
  • Petr Vlček,
  • Libor Šafařík,
  • David Michalský,
  • Květoslav Novák,
  • Jaroslava Dušková,
  • Eliška Václavíková,
  • Jiří Widimský and
  • Tomáš Zelinka

25 April 2019

This work discusses the clinical performance of chromogranin A (CGA), a commonly measured marker in neuroendocrine neoplasms, for the diagnosis of pheochromocytoma/paraganglioma (PPGL). Plasma CGA (cut-off value 150 µg/L) was determined by an i...

  • Article
  • Open Access
31 Citations
7,489 Views
24 Pages

Integrin α10, a Novel Therapeutic Target in Glioblastoma, Regulates Cell Migration, Proliferation, and Survival

  • Matilda Munksgaard Thorén,
  • Katarzyna Chmielarska Masoumi,
  • Cecilia Krona,
  • Xiaoli Huang,
  • Soumi Kundu,
  • Linnéa Schmidt,
  • Karin Forsberg-Nilsson,
  • Marcus Floyd Keep,
  • Elisabet Englund and
  • Sven Nelander
  • + 2 authors

25 April 2019

New, effective treatment strategies for glioblastomas (GBMs), the most malignant and invasive brain tumors in adults, are highly needed. In this study, we investigated the potential of integrin α10β1 as a therapeutic target in GBMs. Expres...

  • Article
  • Open Access
33 Citations
5,147 Views
21 Pages

Deciphering the Elevated Lipid via CD36 in Mantle Cell Lymphoma with Bortezomib Resistance Using Synchrotron-Based Fourier Transform Infrared Spectroscopy of Single Cells

  • Sudjit Luanpitpong,
  • Montira Janan,
  • Kanjana Thumanu,
  • Jirarat Poohadsuan,
  • Napachai Rodboon,
  • Phatchanat Klaihmon and
  • Surapol Issaragrisil

24 April 2019

Despite overall progress in improving cancer treatments, the complete response of mantle cell lymphoma (MCL) is still limited due to the inevitable development of drug resistance. More than half of patients did not attain response to bortezomib (BTZ)...

  • Article
  • Open Access
14 Citations
4,566 Views
17 Pages

Local Injection of Submicron Particle Docetaxel is Associated with Tumor Eradication, Reduced Systemic Toxicity and an Immunologic Response in Uro-Oncologic Xenografts

  • Holly A. Maulhardt,
  • Lauren Hylle,
  • Michael V. Frost,
  • Ashley Tornio,
  • Sara Dafoe,
  • Leanne Drummond,
  • David I. Quinn,
  • Ashish M. Kamat and
  • Gere S. diZerega

24 April 2019

Intratumoral (IT) administration of submicron particle docetaxel (NanoDoce®, NanOlogy LLC, Fort Worth, TX, USA) and its efficacy against genitourinary-oncologic xenografts in rats and mice, xenograft-site docetaxel concentrations and immune-cell...

  • Article
  • Open Access
6 Citations
3,641 Views
9 Pages

Oxaliplatin-Based Chemotherapy in Patients with Metastatic Colorectal Cancer Aged at Least 75 Years: A Post-Hoc Subgroup Analysis of Three Phase II Trials

  • Gerardo Rosati,
  • Stefano Cordio,
  • Giorgio Reggiardo,
  • Giuseppe Aprile,
  • Alfredo Butera,
  • Antonio Avallone,
  • Aniello Tucci,
  • Giuseppe Novello,
  • Giuseppina Blanco and
  • Giuseppe Caputo
  • + 2 authors

24 April 2019

Patients older than 75 years of age are usually excluded from metastatic colorectal cancer studies based on a combination chemotherapy containing oxaliplatin. Our group conducted three phase II trials in elderly patients in recent years. A post-hoc s...

  • Article
  • Open Access
9 Citations
3,655 Views
14 Pages

Histopathological Imaging–Environment Interactions in Cancer Modeling

  • Yaqing Xu,
  • Tingyan Zhong,
  • Mengyun Wu and
  • Shuangge Ma

24 April 2019

Histopathological imaging has been routinely conducted in cancer diagnosis and recently used for modeling other cancer outcomes/phenotypes such as prognosis. Clinical/environmental factors have long been extensively used in cancer modeling. However,...

  • Article
  • Open Access
37 Citations
7,194 Views
17 Pages

Sequential Blockade of PD-1 and PD-L1 Causes Fulminant Cardiotoxicity—From Case Report to Mouse Model Validation

  • Shin-Yi Liu,
  • Wen-Chien Huang,
  • Hung-I Yeh,
  • Chun-Chuan Ko,
  • Hui-Ru Shieh,
  • Chung-Lieh Hung,
  • Tung-Ying Chen and
  • Yu-Jen Chen

24 April 2019

The combined administration of programmed cell death 1 (PD-1) and programmed cell death ligand 1 (PD-L1) inhibitors might be considered as a treatment for poorly responsive cancer. We report a patient with brain metastatic lung adenocarcinoma in whom...

of 16

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694